103 related articles for article (PubMed ID: 21809264)
1. Circulating blasts and associated hematologic disorders in neonates with Down syndrome.
Jackson GL; Sendelbach DM; Rambally B; Manning MD; Engle WD
Am J Perinatol; 2012 Apr; 29(4):259-66. PubMed ID: 21809264
[TBL] [Abstract][Full Text] [Related]
2. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system.
Henry E; Walker D; Wiedmeier SE; Christensen RD
Am J Med Genet A; 2007 Jan; 143A(1):42-50. PubMed ID: 17163522
[TBL] [Abstract][Full Text] [Related]
3. Descriptive study of the complete blood count in newborn infants with Down syndrome.
Martínez-Macías FJ; Bobadilla-Morales L; González-Cruz J; Quiles-Corona M; Corona-Rivera A; Peña-Padilla C; Orozco-Vela M; Silva-Cruz R; Velarde-Rivera F; Corona-Rivera JR
Am J Med Genet A; 2017 Apr; 173(4):897-904. PubMed ID: 28168815
[TBL] [Abstract][Full Text] [Related]
4. Hematological abnormalities in newborn infants with Down syndrome.
Miller M; Cosgriff JM
Am J Med Genet; 1983 Oct; 16(2):173-7. PubMed ID: 6228141
[TBL] [Abstract][Full Text] [Related]
5. [Complete blood count reference values of donated cord blood from Korean neonates].
Lee HR; Shin S; Yoon JH; Kim BJ; Hwang KR; Kim JJ; Roh EY
Korean J Lab Med; 2009 Jun; 29(3):179-84. PubMed ID: 19571613
[TBL] [Abstract][Full Text] [Related]
6. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
7. Hematological disturbances in Down syndrome: single centre experience of thirteen years and review of the literature.
Karakurt N; Uslu İ; Aygün C; Albayrak C
Turk J Pediatr; 2019; 61(5):664-670. PubMed ID: 32104997
[TBL] [Abstract][Full Text] [Related]
8. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for early death in neonates with Down syndrome and transient leukaemia.
Muramatsu H; Kato K; Watanabe N; Matsumoto K; Nakamura T; Horikoshi Y; Mimaya J; Suzuki C; Hayakawa M; Kojima S
Br J Haematol; 2008 Aug; 142(4):610-5. PubMed ID: 18510680
[TBL] [Abstract][Full Text] [Related]
10. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants.
Orozco-Vela M; Corona-Rivera A; Cruz-Osorio RM; Mendoza-Maldonado L; Márquez-Mora A; Barba-Barba CC; Peña-Padilla C; Baldomero-López A; Bobadilla-Morales L; Corona-Rivera JR
Am J Med Genet A; 2020 Sep; 182(9):2085-2093. PubMed ID: 32681702
[TBL] [Abstract][Full Text] [Related]
11. [Neonatal thrombocyte values in children with Down's syndrome and other autosome trisomies].
Thüring W; Tönz O
Helv Paediatr Acta; 1979; 34(6):545-55. PubMed ID: 161560
[TBL] [Abstract][Full Text] [Related]
12. Hematological disorders in Down syndrome: ten-year experience at a Tertiary Care Centre in North India.
Awasthi A; Das R; Varma N; Ahluwalia J; Gupta A; Marwaha RK; Garewal G
Pediatr Hematol Oncol; 2005 Sep; 22(6):507-12. PubMed ID: 16169817
[TBL] [Abstract][Full Text] [Related]
13. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
Zipursky A; Brown EJ; Christensen H; Doyle J
Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia in neonates with polycythemia: incidence, risk factors and clinical outcome.
Vlug RD; Lopriore E; Janssen M; Middeldorp JM; Rath ME; Smits-Wintjens VE
Expert Rev Hematol; 2015 Feb; 8(1):123-9. PubMed ID: 25547250
[TBL] [Abstract][Full Text] [Related]
15. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
Roberts I; Alford K; Hall G; Juban G; Richmond H; Norton A; Vallance G; Perkins K; Marchi E; McGowan S; Roy A; Cowan G; Anthony M; Gupta A; Ho J; Uthaya S; Curley A; Rasiah SV; Watts T; Nicholl R; Bedford-Russell A; Blumberg R; Thomas A; Gibson B; Halsey C; Lee PW; Godambe S; Sweeney C; Bhatnagar N; Goriely A; Campbell P; Vyas P;
Blood; 2013 Dec; 122(24):3908-17. PubMed ID: 24021668
[TBL] [Abstract][Full Text] [Related]
16. Distinctive hematological abnormalities in East Asian neonates and children with Down syndrome.
Kim DW; Kim HR; Shin MG; Baek HJ; Kook H; Hwang TJ; Shin JH; Suh SP; Ryang DW
Int J Lab Hematol; 2011 Aug; 33(4):369-77. PubMed ID: 21692995
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
18. [The effect of lowering the hematocrit on polycythemia and thrombocytopenia in congenital cyanotic heart defect].
de Haan M; de Koning J; Ottenkamp J; Schilte PP
Tijdschr Kindergeneeskd; 1985 Oct; 53(5):178-81. PubMed ID: 2418530
[TBL] [Abstract][Full Text] [Related]
19. Complete blood count parameters for healthy, small-for-gestational-age, full-term newborns.
Ozyürek E; Cetintaş S; Ceylan T; Oğüş E; Haberal A; Gürakan B; Ozbek N
Clin Lab Haematol; 2006 Apr; 28(2):97-104. PubMed ID: 16630213
[TBL] [Abstract][Full Text] [Related]
20. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
Hendricks SK; Sorensen TK; Baker ER
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
